Pinnacle Associates’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,000
Closed -$64K 754
2022
Q1
$64K Sell
20,000
-2,000
-9% -$6.75K ﹤0.01% 778
2021
Q4
$95K Buy
22,000
+6,600
+43% +$35.7K ﹤0.01% 774
2021
Q3
$92K Buy
15,400
+1,100
+8% +$7.37K ﹤0.01% 752
2021
Q2
$118K Buy
14,300
+500
+4% +$4.06K ﹤0.01% 751
2021
Q1
$119K Buy
+13,800
New +$153K ﹤0.01% 722

Other funds holding CGEN

Pinnacle Associates's CGEN Position: Q2 2022 in Review

Pinnacle Associates sold out of Compugen (CGEN) in Q2 2022, closing a stake of 20,000 shares — an estimated $64K sold.

Pinnacle Associates first reported a position in CGEN in Q1 2021 and held it in 5 quarters. The position peaked at $119K in Q1 2021. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

  • Pinnacle Associates reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
  • Pinnacle Associates sold 20,000 Compugen shares in Q2 2022, an estimated $64K.
  • Pinnacle Associates first reported a position in Compugen in Q1 2021 and held it in 5 quarters.
  • Pinnacle Associates's Compugen position peaked at $119K in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on Pinnacle Associates's 13F filing for Q2 2022, filed 2 Aug 2022.